Nicotine
Introduction
Neural signalling and its involvement in modulating innate immune responses has recently come to the fore (Tracey, 2012) . Neuronal signals are rapid, directional, regional and capable of integrating diverse stimuli while inhibiting background noise. These are ideal features to monitor and modulate any complex system. Indeed, in other physiological systems, such as the circulatory, respiratory and digestive system, the main regulator of homeostasis is the nervous system. Close relationships between the nervous, endocrine and immune systems have been described and many works report dual relationships between them: neuroimmune, neuro-endocrine, and immune-endocrine (Rosas-Ballina and Tracey, 2009; Vel azquez-Moctezuma et al., 2014) . However, the specific influence of the nervous system on the immune system remains to be fully elucidated.
The inflammatory reflex is a neural circuit described in mammals that modulates the pro-inflammatory response to avoid the consequences of excessive activity (Tracey, 2010) . This system, when activated by the presence of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) from injured tissue, triggers action potentials through the afferent vagus nerve to the brainstem and other nuclei that control the vagus nerve response (Tracey, 2012) . Efferent responses through the vagal system, also known as the cholinergic antiinflammatory pathway, stimulate the organs of the reticuloendothelial system, including spleen, liver and the gastrointestinal tract Abbreviations: a7nAChR, alpha7 nicotinic acetylcholine receptor; a-BTX, abungarotoxin;
ACh, acetylcholine; NIC, nicotine; poly(I:C), polyinosinic:polycytidylic acid. (Tracey, 2002) . The vagus nerve stimulates the splenic nerve resulting in norepinephrine release by adrenergic nerves (RosasBallina et al., 2011) . In turn, norepinephrine binds to and stimulates lymphocytes present in the spleen, that express choline acetyltransferase (ChAT) that is then able to synthesize acetylcholine (ACh). The lymphocyte derived ACh binds to alpha 7 nicotinic acetylcholine receptors (a7nAChR) present in spleen macrophages. As ACh is released, it is also rapidly hydrolyzed by acetylcholinesterase (AChE) present in mononuclear leukocytes such as T and B cells adding an additional level of control (Kawashima et al., 2012) .
ACh binding to a7nAChR leads to the inhibition of the phosphorylation of inhibitor of NF-kB (IkB) (Yoshikawa et al., 2006) , the downregulation of the activation of mitogen-activated protein kinases (MAPKs) and inhibition of the release of intracellular Ca 2þ stores (Gwak et al., 2007) and the formation of a heterodimeric protein complex with Janus kinase 2 (JAK2), which activates signal transducer and activator of transcription 3 (STAT3) (de Jonge et al., 2005; Yoshikawa et al., 2006) . Together, these signalling pathways lead to inhibition of pro-inflammatory cytokine release.
The a7nAChR is a central component of the inflammatory reflex (Wang et al., 2003) . It belongs to the superfamily of Cys-loop ligand-gated ion channels (Gallowitsch-Puerta and Tracey, 2005) and is a homo-pentamer of alpha 7 subunits activated by ligands such as ACh or nicotine (NIC) (Borovikova et al., 2000; Wang et al., 2003) . The a7nAChR is mainly expressed in the central and peripheral nervous systems, but it is also present in cells of the immune system including monocytes, macrophages, dendritic cells, B and T cells (Kawashima et al., 2007; Sato et al., 1999) . Each receptor has five ACh-binding sites, that are located between adjacent subunits (Papke, 2014) . The agonists ACh and NIC stimulate the a7nACh receptor resulting in a dose-dependent inhibition of the release of pro-inflammatory cytokines including tumor necrosis factor alpha (TNFa), interleukin 1 beta (IL-1b), and interleukin 6 (IL-6) among others, as well as activating the release of antiinflammatory cytokines such as IL-10. Initially, this modulation was thought to be a post-translational phenomenon (Borovikova et al., 2000; Kawashima and Fujii, 2004; Wang et al., 2003) . However, recent studies on macrophages stimulated with LPS and polyinosinic:polycytidylic acid (poly(I:C)) indicated that modulation occurs, both at transcriptional and translational levels (Cui et al., 2013; Yang et al., 2015) .
In teleosts, information regarding the inflammatory reflex is scarce and, although many of the individual protein components of the inflammatory reflex system have been identified in large scale sequencing efforts, no information related to the integrated functioning of the inflammatory reflex has been reported. As indicated above, a principal component of this regulatory system is the a7nAChR. Nicotinic acetylcholine receptors have been characterized in zebrafish (Danio rerio) (Zirger et al., 2003) and fugu (Takifugu rubripes) (Jones et al., 2003) . Three a7nAChR sequences (a7 a, b and c) have been described in the latter, in which the a7a sequence is 1365 pb long, coding for a protein of 454 AA. The protein is expressed in different tissues such as brain, stomach, heart, muscle and gonads (Jones et al., 2003) . In zebrafish, the DNA coding for a7nAChR subunits is 1527 bp, resulting in a protein of 509 AA. The zebrafish a7nAChR has been expressed in Xenopus oocytes and characterized pharmacologically. Results show this a7nAChR is activated by the typical nAChR agonists ACh, NIC and cytisine, as well as by selective a7nAChRs agonists such as choline, tropane, and 4OH-GTS-21 (Papke et al., 2012) . Additionally, transcriptomic studies in zebrafish indicate that a7nAChR expression is downregulated and AChE is up-regulated in brain after a viral infection, suggesting an inhibition of the anti-inflammatory pathway (Boltaña et al., 2013) . Other aspects of the inflammatory reflex such as AChE or ACh levels have been characterized in mononuclear cells from tilapia spleen (Toledo-Ibarra et al., 2014) . In rainbow trout (Oncorhynchus mykiss), Drescher and colleagues have cloned and characterized the a9nAChR from saccular hair cells, analysing the evolution of audition in vertebrates (Drescher et al., 2004) ; but no information about a7nAChRs is available. Here we describe, for the first time, the presence of a7nAChR in rainbow trout and their ability to modulate the inflammatory response.
Materials and methods

Animals
Adult rainbow trout (O. mykiss), 100e120 g body weight, were held in cilindric tanks of 4.6 m 3 total capacity at a density of 7 kg/ m 3 . The installations (4.2 l/min flow rate) worked with a recirculating chiller cooling system, UV-filter, sand filter, and biofilter, with temperature (16 C) and photoperiod controlled (12 h L:12 h D).
Freshwater was always passed through column filters to remove sediments and chlorine before entering into the system. Fish were fed with a commercial pellet at 2.0% of total body weight/day twice a day (Trouw T6 Classics 3P, Spain Rainbow trout were sacrificed by anaesthetic overdose with MS-222 (300 mg/l, Sigma-Aldrich, USA). Brain and spleen were removed and immediately frozen in liquid nitrogen, and stored at À80 C until use. Total RNA was extracted using TriReagent (Sigma-Aldrich) following manufacturer's instructions, including a DNase (Sigma-Aldrich) treatment step (0.25 U/ml for 500 ng RNA, 30 min 37 C). RNA concentration and quality were evaluated using the Nanodrop ND-1000 (Thermo Fisher Scientific, USA) and the Bioanalyser-2100 with the RNA 6000 Nano Kit (Agilent Technologies, USA), respectively. All the samples had a RIN higher than 7.5. cDNA was synthesized with 1000 ng of total RNA in a final volume of 20 ml using SuperScript III reverse transcriptase (Invitrogen, USA) and oligo-dT 15 primer (Promega, USA) according to the manufacturer's instructions. RT-PCR was carried out using 1 ml of cDNA with specific primer pairs (Supplemental Table 1 ). Elongation factor 1 alpha (EF1a) was used as a reference gene. PCR products were separated on 1% agarose gels stained with GelGreen (Biotium, USA).
Rainbow trout a7nACh receptor cloning
The cloning of rainbow trout a7nAChR was achieved by first analyzing the a7nAChR nucleotide and protein sequences available in public databases (The National Center for Biotechnology Information, NCBI, and Universal Protein Resource, UniProt). Alignments of a7nAChR sequences from different species were done using ClustalX v2.1 and degenerate primers were designed in conserved regions (Supplemental Table 1 ). Full length a7nAChR was cloned from brain using 3 0 and 5 0 -RACE (Life Technologies, USA) following manufacturer's instructions with gene specific primers (Supplemental Table 1 ). PCR products were isolated with Nucleospin Gel and PCR Clean-up (Macherey-Nagel, Germany) and cloned into pGEM-T Easy Vector (Promega) in Escherichia coli DH5a cells (Life Technologies) following manufacturer's instructions. Plasmid clones were isolated using the Nucleospin Plasmid QuickPure kit (Macherey-Nagel) and digested with EcoRI (Thermo Fisher Scientific). The plasmids were sequenced using SP6 and T7 primers with the sequencing kit BigDye Terminator v3.1 Cycle Sequencing (Applied Biosystems, USA) in the sequencer 3 130xl Genetic Analyzer (Applied Biosystems).
Domain structure and phylogenetic analysis
The predicted amino acid sequence and domain features of a7nAChR were identified and annotated with BankIt from NBCI (accession number: KT634308). The characteristic domains of the protein sequence were identified with the following analysis tools: Simple Modular Architecture Research Tool (SMART), Pfam, NetNglyc v1.0 server, NetPhos v2.0 server and SignalP v4.1 web-based analysis tools. The BLAST suite was used to search for nucleotide and protein sequence similarities and the retrieved sequences were aligned and analysed with ClustalX.
Algorithm approaches for the phylogenetic analysis included a Bayesian Markov Chain Monte Carlo (MCMC) analysis implemented in BEAST v2.2 and a bootstrapped maximum likelihood (ML) estimation of phylogenetic relationships between taxa using the RaxML package. Periplaneta americana was chosen as the outgroup. The MCMC analysis ran for 10 7 generations, using a General Time
Reversible model with gamma-distributed rate variation across sites for substitution rates (GTR þ I þ G), a relaxed lognormal molecular clock to model the branch length and the Yule model of branching. Tracer v1.6 was used to evaluate the non-discarded generations (10% were rejected as burn-in) for convergence and mixing (sampling efficiency of parameters). The GTR þ I þ G ML majority rule extended consensus trees were evaluated after 10 4 bootstrap replicates.
The a7nAChR tissue distribution
Rainbow trout (n ¼ 3) were stimulated with LPS or poly(I:C) to compare the a7nAChR tissue distribution under basal and stimulated conditions. Fish were anesthetized with MS-222 and intraperitoneally (i.p.) injected with either 160 ml of LPS (8 mg/kg) (E. coli 0111:B4, Sigma-Aldrich), 450 ml of poly(I:C) (3 mg/kg) (Invivogen, USA) or sterile PBS (control) (Das et al., 2009; MacKenzie et al., 2008) . After 12 h the animals were sacrificed by anaesthetic overdose, and brain, spleen, head kidney, posterior kidney, white muscle, red muscle, liver, intestine, heart and gills were removed and immediately frozen in liquid nitrogen and stored at À80 C until use. The tissues were homogenized with a Polytron PT-MB 1600 E (Kinematica, Germany). RNA extraction, cDNA and RT-PCR were performed as described above (see section 2.2) using a7nAChR specific primers (Supplemental Table 1 ).
Acetylcholine levels in rainbow trout serum and spleen
Fish were anesthetized (MS-222, 50 mg/l) and i.p. injected with either 160 ml of LPS (8 mg/kg), 450 ml of poly(I:C) (3 mg/kg) or steril PBS (control). At different time points (0, 10, 20, 30, 60, 90, 180 and 720 min) 4 animals for each treatment were sacrificed by anaesthetic overdose with MS-222 at 300 mg/l. Blood samples were obtained and centrifuged at 1200 xg for 15 min at 4 C to obtain the plasma. Spleens were removed and immediately frozen in liquid nitrogen, then all samples were stored at À80 C until use. Spleens were homogenized with a Polytron PT-MB 1600 E in 400 ml of cold PBS 1% Triton X-100 (Sigma-Aldrich), then centrifuged at 16000 xg for 10 min at 4 C and the supernatants were recovered. The ACh measurements were done using the Amplex Red acetylcholine assay kit (Invitrogen) following manufacturer's instructions. The results were analysed using One-way ANOVA followed by Tukey's post-hoc test (GraphPad Prism software v5, USA).
Cell cultures
Rainbow trout macrophages from spleen (SPM) and head kidney (HKM) were cultured as described previously (Roher et al., 2011) using DMEM 4.5 g/l glucose supplemented with 10% (v/v) heat inactivated FBS and Primocin (Invivogen) and incubated at 16 C and 5% CO 2 . The expression pattern of the a7nAChR and a9nAChR genes in trout macrophages was analysed by RT-PCR using monocytes/macrophages from day 1 to day 6 of differentiation. RNA extraction, first-strand cDNA synthesis and conventional PCR were performed as described above (see section 2.2).
Phagocytosis assays
The effects of ACh and NIC on macrophage phagocytosis were analysed by flow cytometry (FACS-Canto, Becton Dickinson). We used zymosan a glucan that mimics a fungi infection as particles to be phagocytized. For the dose-response assay, HKM cells were seeded in 12-well plates at 80% confluence. Cells were incubated with ACh (Sigma-Aldrich) at different doses (0.1, 1, 10, 100 and 1000 mM) 20 min before adding the zymosan FITC-conjugate (Life Technologies) at a 5:1 ratio (zymosan particle/macrophage) for 15 and 30 min. For the time-course assay, cells were incubated with 500 mM of ACh or 100 mM of NIC (Sigma-Aldrich) 20 min before adding the zymosan at indicated times (5, 10 and 30 min). After incubation, the medium was removed and cells were rinsed with PBS to eliminate non-phagocytosed zymosan particles. The macrophages were detached with TrypLE Express (Life technologies) and centrifuged at 300 xg for 5 min. Pellets were resuspended in 200 ml of PBS and analysed by cytometry. Both experiments were repeated in triplicate and for each sample 10,000 events were recorded. The results were analysed using One-way ANOVA followed by Tukey's post-hoc test.
a-Bungarotoxin binding assay
We used a-bungarotoxin (a-BTX) to identify the presence of the a7nAChR in the plasma membrane of macrophages. The a-BTXbinding was evaluated by flow cytometry (FACS-Canto) and confocal microscopy (Zeiss LSM700, Germany). Briefly, for cytometry, HKM and SPM cells were seeded in 6-well plates at 80% confluence. For the binding assay, cells were incubated in suspension (final volume of 200 ml medium). Cells were stimulated with 100, 500 or 1000 mM of nicotine (NIC) (Sigma-Aldrich) for 20 min and then 1.5 mg/ml of a-BTX Alexa Fluor 647 conjugate (a-BTX-AF647) (Life Technologies) was added and left for 1 h at room temperature. In another experiment, cells were stimulated with 20 mg/ml of poly(I:C) (Ruyra et al., 2015) or 10 mg/ml of LPS (Mackenzie et al., 2003) for 2 h and then 1.5 mg/ml of a-BTX-AF647 (Life Technologies) was added and left for 1 h. After each experiment, the medium was removed, cells were rinsed with PBS to remove non-bound a-BTX and then were analysed by cytometry. To discard citotoxic effects at supra-physiological doses of NIC we performed MTT assays in HKM (data not shown). We did not observe NIC or ACh toxicity at any of the assayed concentrations. The experiments were done in triplicate and for each sample 10,000 events were recorded. The results were analysed using Oneway ANOVA followed by Tukey's post-hoc test. For confocal microscopy, HKM cells were seeded in individual plates at 60% confluence. Cells were incubated in suspension with 1.5 mg/ml of a-BTX for 1 h at room temperature. After 3 washes with PBS, cells were labelled with Hoechst 33342 (10 mg/ml). Images were analysed with Imaris software v8.1 (Bitplane AG, Switzerland).
qPCR gene expression studies
HKM cells were seeded in 6-well plates at 80% confluence. Cells were incubated with 1.5 mg/ml of a-BTX for 30 min, then 100 mM of NIC was added (20 min) and finally the cells were treated with 10 mg/ml LPS or poly(I:C) for 12 h. The treatments were: control, NIC, a-BTX, LPS, NIC þ LPS/poly(I:C) and a-BTX þ NIC þ LPS/ poly(I:C). The RNA extraction and first-strand cDNA synthesis were performed as described above (see section 2.2). The genes selected to evaluate the LPS response were: IL-1b, TNFa, IL-6, Chemokine (C-C Motif) Ligand 4 (CCL4), CC chemokines CK6 (CK6), MMP9, Cathelicidin 1 (CAMP 1) and Suppressor of Cytokine Signalling 3 (SOCS3). The genes selected to evaluate the poly(I:C) response were: CCL4, IL-1 b, IL-6, TNFa, Type I Interferon (IFN-1), Myxovirus resistance (Mx-1), Melanoma differentiationassociated protein 5 (MDA5), Viperin-1 (vig-1), Toll like receptor-3 (TLR3), Toll like receptor-7 (TLR7) and Toll like receptor-8 (TLR8). EF1a was used as a reference gene. qPCR was carried out using SYBR Green I PCR Supermix (Bio-Rad, USA), 250 nM of primers (Supplemental Table 1 ) and 2.5 ml of cDNA previously diluted (1:50 for target mRNA and 1:500 for the reference gene) in 10 ml of final volume. Quantification was done according to the Livak method (Livak and Schmittgen, 2001 ). All samples were run in triplicate and the results were analysed using One-way ANOVA followed by Tukey's post-hoc test. Amplification efficiencies of all target genes were calculated and always were between 90 and 100%. Amplification efficiencies were not included in the calculations. All qPCR analysis were performed according to MIQE guidelines (Bustin et al., 2009 ).
Results
Rainbow trout a7nACh subunit cloning and phylogeny
The length of the rainbow trout a7 subunit of the nicotinic acetylcholine receptor cDNA was 2106 bp, containing a 217 bp 5 0 UTR, a 1763 bp ORF and an incomplete 126 bp 3 0 UTR. The ORF of the rainbow trout a7nACh receptor (acc. number: KT634308) codes for a protein of 587 AA with an estimated molecular weight of 65.4 kDa. The a7 subunit has the main characteristics of alpha subunits of the nicotinic acetylcholine receptor. It has a 36 AA signal peptide and an extracellular domain of 210 AA including the disulfide bond (C128-C142) typical of these ligand-activated channels (Fig. 1) . In the extracellular domain we also found two characteristic cysteines in the binding site (C190 e C191) that are distinctive to the a subunits of the nicotinic receptor family (Fig. 1) . In addition, the extracellular domain contained the loops forming the AChbinding site. Indeed, we found three loops forming the principal component of the ACh-binding site: loop A (W86 e Y93), loop B (W149 e M156), loop C (T182 e D197), and the three loops that form the complementary component: loop D (W 55e W60), loop E (K105 e L119) and loop F (N161 e I165) (Fig. 1) . In trout, the amino acids hypothetically in contact with ACh are: loop A: W86 and Y93; loop B: W149 and W154; loop C: Y188, C190, C191 and Y195; loop D: W55 and R57; loop E: L109, N111, E117 and L119, and loop F: E162 and D164. The loop sequences in rainbow trout were highly conserved when compared with other species of mammals (Homo sapiens and Mus musculus), bird (Gallus gallus) and fish (Poecilia reticulata, Esox lucius, D. rerio, T. rubripes and Haplochromis burtoni) (Supplemental Fig. 1 ). Furthermore, in the extracellular domain, three putative glycosylation sites (N24, N68 and N111) were located as in other species (Gault et al., 1998; Seguela et al., 1993) . The transmembrane domain contained four transmembrane regions (TM1: Y210 -L232; TM2: I240 -M261; TM3: I271 -V292 and TM4: L521 -V543). As expected, the cytoplasmic loop between TM3 and TM4 was poorly conserved compared with other vertebrate species (Supplemental Fig. 1 ). This region is typically less conserved and the 228 AA rainbow trout sequence was unusually longer than in other species, such as H. sapiens (156 AA), G. gallus (156 AA) or D. rerio (162 AA), but similar to T. rubripes (207 AA length). Finally, three putative phosphorylation sites were found in the cytoplasmic loop (S345, S429 and Y491), similarly to other species (Gault et al., 1998; Moss et al., 1996; Seguela et al., 1993) (Fig. 1) . Summarizing, except for the extremely long cytoplasmic domain, the rainbow trout a7nAChR sequence is highly conserved when compared with other vertebrate a7 sequences. Regarding the structure of the a7nAChR gene, analysis of its exon-intron boundaries showed its distribution among 9 exons, while in other species, such as H. sapiens, G. gallus or D. rerio (Ensembl, 2013a, b, c; Gault et al., 1998 ) the gene contains 10 exons. The rainbow trout gene contains a larger first exon when compared to other species. Sequence analysis suggests that this first exon corresponds to the first and second exons of the other species, while the rest of the structure is homologous (Supplemental Fig. 2 A and 2B; Supplemental Methods).
Phylogenetic analysis demonstrated that the a7nAChR in the taxa selected converged to the same topology, with branching differing in each phylogenetic estimation. O. mykiss shares 87,7% similarity in nucleotidic sequence with E. lucius, and 79,4%, 78,1% and 75,6% similarity to P. reticulate, H. burtoni, and T. rubripes respectively (Fig. 2) .
a7nAChR tissue distribution
a7nAChR tissue distribution was evaluated by conventional RT-PCR. Under basal conditions, the receptor was present in all tissues. The pattern of gene expression in different tissues was maintained after poly(I:C) and LPS injection, (Fig. 3A) .
LPS and poly(I:C) increase the ACh levels in plasma and spleen
T lymphocytes are able to produce ACh in response to PAMPs, DAMPs or damaged tissue (Rosas-Ballina et al., 2011) . Based on this precedent, fish were stimulated with LPS or poly(I:C) in vivo to assess whether they were able to modulate the levels of ACh in plasma and spleen in response to PAMPs. Our results show that poly(I:C) stimulates the release of ACh both in plasma and spleen. In plasma we observed a significant increase of ACh at 30 min (1.17 ± 0.41 fold-change, p<0.01) (Fig. 3B (i) ) and in spleen at 20 and 30 min post-stimulation (3.27 ± 0.84 fold-change, p<0.01; 3.42 ± 0.28 fold-change, p<0.01, respectively) ( Fig. 3B (ii) ). The results show a similar trend in fish treated with LPS. We observed an ACh increase in plasma (2 ± 0.01 fold-change, p<0.0001) 30 min after LPS injection (Fig. 3B (iii) ). A similar result was observed in spleen, where treated animals increased ACh levels (1.8 ± 0.44 foldchange, p<0.0001) 180 min after the LPS treatment (Fig. 3B (iv) ). These results highlight that different PAMPs can stimulate the cholinergic anti-inflammatory pathway by increasing the production of ACh.
Gene expression of a7nAChR and a9nAChR in spleen and head kidney macrophages
Next, we characterized the presence of acetylcholine receptors in rainbow trout macrophages by conventional RT-PCR. The a9AChR (a9-I, a9-II and a9-III) had already been cloned and characterized in rainbow trout (Drescher et al., 2004) and since both a7 and a9 AChR subunits are able to bind a-BXT, we evaluated their expression during macrophage differentiation. a7nAChR was expressed throughout the whole differentiation process (Fig. 4A ).
a7nAChR expression was observed both in head kidney and spleen derived macrophages. In contrast, a9-I, a9-II and a9-III subunits were not expressed in head kidney and spleen macrophages (Fig. 4B) . The absence of a9AChR isoforms is relevant because a-BTX is able to bind to a7nAChR and a9AChR as well. These results supported the use of a-BTX as a tool to identify the presence of a7nAChR in the membrane of trout macrophages since binding of a-BTX would indicate exclusively the presence of a7nAChR. 
HKM and SPM bind a-BTX and NIC decreases a-BTX-binding
To assess the presence of the a7nAChR in the membrane of macrophages we used a-BTX, which is an acetylcholine receptor antagonist that binds irreversibly to the a7nAChR (Moss et al., 1996) . As explained above, rainbow trout macrophages obtained from spleen and head kidney express a7nAChR but not a9nAChR (Fig. 4B) , thus a-BTX-binding indicates the unique presence of the spleen; HK: head kidney; PK: posterior kidney; WM: white muscle; RM: red muscle; L: liver; I: intestine; G: gills and H: heart. (B) ACh levels in rainbow trout plasma and spleen homogenate after poly(I:C) and LPS in vivo stimulation. ACh levels after a i.p. injection of poly(I:C) and LPS. The samples of plasma (i and iii) and spleen (ii and iv) were taken at different times (0, 20, 30, 60, 90, 180 and 720 min) . The ACh measurements were done using the Amplex Red acetylcholine assay kit. Fold-change was calculated in reference to the control. Differences were analysed using One-way ANOVA followed by Tukey's post-hoc test; data represent mean ± SD (n ¼ 4). Significant differences with respect to control **, p < 0.01; ***, p<0.0001. a7nAChR in our experimental model. In the same set of experiments, we also evaluated the effect of nicotine (an agonist of the acetylcholine receptor) on a-BTX-binding. Firstly, we observed that HKM cells were able to bind a-BTX (22.7 ± 4% of macrophages that are positive to a-BTX, p<0.0001) (Fig. 5A (i) ) and secondly NIC was able to decrease a-BTX-binding in a dose-dependent manner (e.g. 12.6 ± 1.5% at 500 mM of NIC, p<0.0001). The partial inhibition of a-BTX by NIC could be due to unknown NIC metabolism activities that could provoked a decrease in the NIC availability or could be due to unknown ligand-receptor trafficking events. Also, SPM cells were able to bind a-BTX (34.9 ± 0.5% a-BTX-binding, p<0.0001) (Fig. 5A (ii)) and the lowest NIC concentration decreased a-BTX-binding in these cells (19.1 ± 10%, p<0.01). At least two different functional populations of macrophages (M1 and M2) have been described by different authors (see Wiegertjes et al., 2016 for a review). Our a-BTX binding results indicate that probably only a particular subpopulation of HKM or SPM express a7nAChR and is able to bind a-BTX (22.7 ± 4% of HKM and 34.9 ± 0.5% of SPM are able to bind a-BTX).
Confocal microscopy and 3D reconstruction images enabled the visualization of a-BTX-binding to the membrane of HKM (Fig. 5B (iiv) ). Additionally, we observed that pre-stimulation of the HKM cells with poly(I:C) increased a-BTX-binding (47.5 ± 6.4% and 32.8 ± 3.4% a-BTX-binding in cells stimulated with or without poly(I:C) respectively, p<0.05) (Fig. 5C (i) ). In contrast, this phenomenon was not observed in cells stimulated with LPS ( Fig. 5C (ii)).
ACh and NIC do not modulate phagocytosis in HKM
Phagocytosis is a key function of macrophages (Secombes and Fletcher, 1992) . To explore whether ACh and NIC could modulate phagocytosis in fish macrophages we stimulated HKM with ACh or NIC before incubation with labelled zymosan. Note we used HKM instead of SPM because the yield and the life span under cell culture conditions was greater in HKM. Results showed that ACh and NIC were not able to modulate phagocytic activity in HKM (Fig. 6A) . In dose-response assays our results indicated that ACh even at supraphysiological concentrations did not have significant effects on phagocytosis (61 ± 11% control cells and 60 ± 8% cells treated with 1000 mM of ACh, respectively) (Fig. 6A) . Regarding time-course assays we did not observe significant differences in phagocytic activity at different time points. For example: at 10 min: 50.8 ± 2.3% zymosan cells, 53.8 ± 6.5% cells treated with ACh and 57.7 ± 12.7% cells treated with NIC; at 15 min: 60.0 ± 3.7% zymosan cells, 59.3 ± 6.2% cells treated with ACh and 60.1 ± 2% cells treated with NIC; (Fig. 6B) .
NIC modulates the expression of immune response genes after stimulation with poly(I:C)
A set of experiments were designed aiming to describe the basis of the macrophage response during the inflammatory reflex. We tested combinations of NIC, PAMPs and a-BTX. Our results showed, that NIC inhibited the increase of the antiviral gene expression induced by poly(I:C). Antiviral genes such as, IFN-1, Mx-1, CCL4, CK6 and vig-1 were down-regulated by NIC (e.g. Mx-1: 25 ± 4 fold change after poly(I:C) treatment and 8 ± 11 fold change after NIC þ poly(I:C) treatment, p<0.001). We also assessed the expression of different toll-like receptors such as, TLR3 and TLR8 and the results showed that NIC was also able to down-regulate TLR3 expression (2.65 ± 0.5 fold change after poly(I:C) treatment and 1.5 ± 0.3 fold change after NIC þ poly(I:C), p<0.01), the same trend for TLR8 expression was observed without significant differences (Fig. 7) .
In parallel, we observed that in cells pre-treated with a-BTX the effects of NIC were attenuated (e.g. Mx-1: 25 ± 7 fold change in a-BTX þ NIC þ poly(I:C) treated cells and TLR3: 2.1 ± 0.1 fold change in a-BTX þ NIC þ poly(I:C) treated cells, p<0.001) (Fig. 7) . These results suggest a competition between a-BTX and NIC for the binding site. However, when we evaluated the gene expression of pro-inflammatory cytokines such as, TNFa, IL-6 and IL-1b we did not find any effect of NIC (data not shown). As well, the expression of genes such as, TNFa, IL-6, IL1-b, CCL4, CK6, CAMP1, SOCS3, MMP9
were not modulated by NIC in cells treated with LPS (Supplemental Fig. 3 ).
Discussion
The a7nAChR is a key player controlling the inflammatory reflex.
This receptor is one of the signalling molecules regulating cytokine expression in macrophages through the binding of ACh. In rainbow trout, the amino acids hypothetically in contact with ACh are highly conserved when compared with other vertebrate species (e.g. H. sapiens, G. gallus, D. rerio and T. rubripes) (Supplemental Fig. 1 ). The amino acids contributing to the ACh-binding site are organized in six loops (Corrienger et al., 2000) . When we compared the AChbinding site of trout and human sequences we observed only two different residues in loop D (Q57 / R57) and in loop E (Q117 / E117). However, these amino acids were not always conserved in other species (Supplemental Fig. 1) . Therefore, the differences between these amino acids should not affect the ability of a7nAChR to bind ACh. Also, the residues involved in a-BTX binding are (i) HKM were incubated with 100, 500 or 1000 mM of NIC 20 min before adding 1.5 mg/ml a-BTX-AF647 for 1 h (ii) SPM were incubated with 100 mM of NIC 20 min before adding 1.5 mg/ml a-BTX for 1 h. (B) Confocal microscopy images of a-BTX-binding (red) in HKM. Cells were incubated 1 h with 1.5 mg/ml of a-BTX-AF647. Hoechst (blue) was used for nuclei labelling. (i) Control cells, (ii) HKM cells at 1 h after addition of a-BTX-AF647, (iii) 3D image reconstruction of a whole cell and (iv) longitudinal stack of the cell showing the nuclei. (C) The a-BTX-binding in HKM after a stimulation with (i) poly(I:C) and (ii) LPS. Differences were analysed using One-way ANOVA followed by Tukey's post-hoc test. Data represent means ± SD (n ¼ 3). Significant differences with respect to a-BTX: *, p<0.05; **, p<0.01; ***, p<0.001.
conserved (Sine, 2002) . In fact, a phenylalanine and two tyrosines in loop C are essential to maintain high affinity for a-BTX Sine et al., 2013) . These residues are present in the rainbow trout sequence (F187, Y188 and Y195) (Fig. 8A) , indicating that the receptor would be able to bind a-BTX with high affinity. This prediction was confirmed by our experiments in vitro. Trout macrophages did bind a-BTX, and this binding was partially inhibited by NIC. This result has been previously described in human macrophages, where incubation with NIC before the addition of a-BTX, provoked a decrease in neurotoxin binding (Cui et al., 2013; Wang et al., 2003) . The NIC concentrations used in our study were similar to those of other studies (Wang et al., 2003; Borovikova et al., 2000) and are considered supra-physiological doses and are mainly used as a tool to understand the inflammatory reflex.
Additionally, the stimulation of trout macrophages with poly(I:C), before a-BTX addition, induced a significant increase in a-BTX-binding which was not observed in cells treated with LPS. This indicates that stimulation with poly(I:C) increased the presence of a7nAChR in the plasma membrane. In mammals LPS induces an increase in a7nAChR in the membrane, enhancing a-BTX -binding 9 h after stimulation (Corrienger et al., 2000) . Our results in trout
show that LPS can stimulate a7nAChR gene expression 12 h after the stimulation, however it was not able to increase a-BTX-binding.
These results would suggest that LPS-driven signalling requires more time to induce an increase in a7nAChR at the membrane in comparison with poly(I:C). To see if we could obtain active receptor channels in vivo, we injected RNA coding for the trout a7nAChR subunit into Xenopus oocytes. However, this failed to yield a functional nACh receptor (data not shown). This was the case even when the RNA was coinjected with the human chaperone resistance-to-cholinesterase 3 (RIC-3), which is essential for the correct folding of the receptor (Bennett et al., 2012; Castelan et al., 2008 ). An explanation for this lack of activity could be that other a7nAChR isoforms exist and they are, in fact, the active ones. In chicken and mammals a7 single genes have been described while in fugu at least 3 different a7 sequences were found but no functional experiments were performed for any of these isoforms (Jones et al., 2003) . In an in-silico analysis we found a non-annotated protein sequence (CDQ72725) with high similarity to our receptor sequence (Supplemental Figs. 4A and 4B) . However, we did not find any evidence of its gene expression in trout macrophages or tissues (data not shown). Our hypothesis is that this sequence (CDQ72725) could be an alpha7 paralog that has evolved after genome duplication as a pseudogene. Another relevant factor concerning the lack of expression of trout a7nAChR observed in Xenopus, is the unusual length of the cytoplasmic region between the TM3 and TM4 segments. Note that this region is considered to be crucial for the correct expression, folding and trafficking of a7nAChR to the plasma membrane, as tested using mutants of rat a7nAChR (Castel an et al., 2007; Valor et al., 2002) (Fig. 8B ).
Different PAMPs stimulated the expression of the a7nAChR in various trout tissues in vivo. However, a7nAChR was mainly expressed in brain which is consistent with the function of these receptors in the central nervous system modulating distinct neural functions (Lindstrom, 1997) . In trout the highest expression after PAMPs stimulation was observed in the posterior kidney, head kidney, liver and muscle. There is limited information related to the . Gene expression analysis in HKM cells treated with NIC and a-BTX prior to stimulation with poly(I:C). Gene expression was analysed by qPCR in HKM cells previously treated with NIC alone or in the presence of a-BTX. In the latter case, cells were incubated with 1.5 mg/ml of a-BTX for 30 min, then 100 mM of NIC was added for 20 min and finally 10 mg/ml of poly(I:C) for 12 h. Fold-change values compared with the control. Differences were analysed using One-way ANOVA followed by Tukey's post-hoc test. Data represent means ± SD (n ¼ 4). Significant differences between treatments: *, p < 0.05; **, p < 0.01; ***, p < 0.001. tissue distribution of the nicotinic receptors, because characterization studies have focused mainly on brain and immune cells (T cells, B cells, monocytes, macrophages and dendritic cells) (Kawashima et al., 2007; Sato et al., 1999) . However, the a7nAChR (isoform a7a) in fugu has been detected in brain, gills, gonads, stomach, heart and muscle (Jones et al., 2003) , and the rt-a9nAChR (isoform I, II and III) in tissues such as, brain, spleen, liver, pituitary gland and retina (Drescher et al., 2004) . We detected trout a7nAChR in macrophages from spleen and head kidney, consistent with what has been described in mammals (Borovikova et al., 2000; Cui et al., 2013; van der Zanden et al., 2009) .
Our results showed that both poly(I:C) and LPS increased plasma and spleen ACh levels very rapidly. ACh has been detected in blood and plasma of different mammalian species such as human, rat, sheep, rabbit and horse ranging from 33 ± 10 pg/ml to 2254 ± 231 pg/ml (Kawashima and Fujii, 2004; Kawashima et al., 2012) . The basal levels described in Nile tilapia mononuclear cells were 23.55 ± 6.03 mM (3358 Â 10 3 pg/ml) (Toledo-Ibarra et al., 2014) .
Neither NIC nor ACh could modulate phagocytosis in trout macrophages in agreement with previous studies in human monocytes and macrophages (Neumann et al., 2007) . However, our results indicate that NIC modulates the immune response after stimulation with poly(I:C), but not with LPS at the concentration and time points tested. In mammals the activation of the a7nAChR with poly(I:C) and LPS induces a decrease of pro-inflammatory cytokines such as TNFa, IL-1b, IL-6 and IL-8, both at mRNA and protein levels (Borovikova et al., 2000; Cui et al., 2013; Wang et al., 2003) . We observed a modulation of the expression of genes involved in the antiviral response (IFN-1, Mx-1, CCL4, vig-1 and TLR3), but not those involved in the pro-inflammatory response (TNFa, IL-6 and IL-1b) after a stimulation with poly(I:C). The regulation observed occurs via the a7nAChR, because the addition of a specific antagonist (a-BTX) produces a decrease in the NIC effect, thus increasing the gene expression of antiviral genes.
The specific effects of poly(I:C) compared to those of LPS may occur because fish are much less sensitive to LPS than mammals (Mackenzie et al., 2003) . The absence of LPS co-receptor molecules such as MD2 and CD14 in the fish genome might explain this (Sepulcre et al., 2009) . Consequently, in fish it would not be imperative to activate additional homeostatic control to prevent overstimulation of the immune response by LPS. In contrast, in mammals LPS can cause septic shock and the system should be under tight control (Vincent et al., 2013) . In contrast, the antiviral response through TLR3 is highly conserved in vertebrates and orthologs of mammalian viral receptors have been reported in different fish species, such as trout, zebrafish and salmon (Phelan et Our results demonstrate for the first time the functional conservation of the inflammatory reflex in teleosts. The novel teleost a7nAChR is found in macrophages modulating the innate immune response, as is found in mammals.
